The Emerging Functions of Long Noncoding RNA in Immune Cells: Autoimmune Diseases

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Sigdel, Keshav Raj ^a,b   Cheng, Ao ^a,b   Wang, Yin ^a,b   Duan, Lihua ^a   Zhang, YanLin ^a,b  

^a XIAMEN UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA;

AUTOIMMUNE DISEASE; AUTOIMMUNE THYROID DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; REVIEW; RHEUMATOID ARTHRITIS; RNA ANALYSIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; THYROID DISEASE; ANIMAL; GENETICS; IMMUNITY; IMMUNOLOGY;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; IMMUNITY; RNA, LONG NONCODING;

EID: 84930958481     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/848790     Document Type: Review

References (68)

1. P. Carninci, T. Kasukawa, S. Katayama et al., "The transcriptional landscape of the mammalian genome," Science (New York, N.Y.), vol. 309, no. 5740, pp. 1559-1563, 2005.
2. E. Birney, J. A. Stamatoyannopoulos, A. Dutta et al., "Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project," Nature, vol. 447, no. 7146, pp. 799-816, 2007.
3. C. Liu, B. Bai, G. Skogerbø et al., "NONCODE: an integrated knowledge database of non-coding RNAs," Nucleic Acids Research, vol. 33, supplement 1, pp. D112-D115, 2005.
4. J. E. Wilusz, H. Sunwoo, and D. L. Spector, "Long noncoding RNAs: functional surprises from the RNA world," Genes & Development, vol. 23, no. 13, pp. 1494-1504, 2009.
5. D. Bhartiya, K. Pal, S. Ghosh et al., "LncRNome: a comprehensive knowledgebase of human long noncoding RNAs," Database, vol. 2013, Article ID bat034, 2013.
6. J. Zhao, B. K. Sun, J. A. Erwin, J.-J. Song, and J. T. Lee, "Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome," Science, vol. 322, no. 5902, pp. 750-756, 2008.
7. T. R. Mercer, M. E. Dinger, and J. S. Mattick, "Long non-coding RNAs: insights into functions," Nature Reviews Genetics, vol. 10, no. 3, pp. 155-159, 2009.
8. K. C. Wang and H. Y. Chang, "Molecular mechanisms of long noncoding RNAs," Molecular Cell, vol. 43, no. 6, pp. 904-914, 2011.
9. E. A. Gibb, E. A. Vucic, K. S. S. Enfield et al., "Human cancer long non-coding RNA transcriptomes," PLoS ONE, vol. 6, no. 10, Article ID e25915, 2011.
10. M. A. Faghihi, F. Modarresi, A. M. Khalil et al., "Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of β-secretase," Nature Medicine, vol. 14, no. 7, pp. 723-730, 2008.
11. R. McPherson, A. Pertsemlidis, N. Kavaslar et al., "A common allele on chromosome 9 associated with coronary heart disease," Science, vol. 316, no. 5830, pp. 1488-1491, 2007.
12. J. Li, Z. Xuan, and C. Liu, "Long non-coding RNAs and complex human diseases," International Journal of Molecular Sciences, vol. 14, no. 9, pp. 18790-18808, 2013.
13. S. Carpenter, D. Aiello, M. K. Atianand et al., "Along noncoding RNA mediates both activation and repression of immune response genes," Science, vol. 341, no. 6147, pp. 789-792, 2013.
14. S. P. Collier, P. L. Collins, C. L. Williams, M. R. Boothby, and T. M. Aune, "Cutting edge: influence of Tmevpg1, a long intergenic noncoding RNA, on the expression of Ifng by Th1 cells," The Journal of Immunology, vol. 189, no. 5, pp. 2084-2088, 2012.
15. J. A. Gomez, O. L. Wapinski, Y. W. Yang et al., "The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-γ locus," Cell, vol. 152, no.4,pp. 743-754, 2013.
16. + T cells," The Journal of Immunology, vol. 182, no. 12, pp. 7738-7748, 2009.
17. G. Hu, Q. Tang, S. Sharma et al., "Expression and regulation of intergenic long noncoding RNAs during T cell development and differentiation,"Nature Immunology, vol. 14,no. 11,pp. 1190-1198, 2013.
18. P. Wang, Y. Xue, Y. Han et al., "The STAT3-binding long noncoding RNA Inc-DC controls human dendritic cell differentiation," Science, vol. 344, no. 6181, pp. 310-313, 2014.
19. S. Shirasawa, H. Harada, K. Furugaki et al., "SNPs in the promoter of a B cell-specific antisense transcript, SAS-ZFAT, determine susceptibility to autoimmune thyroid disease," Human Molecular Genetics, vol. 13, no. 19, pp. 2221-2231, 2004.
20. C. S. Lee, A. Ungewickell, A. Bhaduri et al., "Transcriptome sequencing in Sézary syndrome identifies Sézary cell and mycosis fungoides-associated IncRNAs and novel transcripts," Blood, vol. 120, no. 16, pp. 3288-3297, 2012.
21. J. Verma-Gaur, A. Torkamani, L. Schaffer, S. R. Head, N. J. Schork, and A. J. Feeney, "Noncoding transcription within the Igh distal VH region at PAIR elements affects the 3D structure of the Igh locus in pro-B cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 42, pp. 17004-17009, 2012.
22. R. K. Dave, M. E. Dinger, M. Andrew, M. Askarian-Amiri, D. A. Hume, and S. Kellie, "Regulated expression of PTPRJ/CD148 and an antisense long noncoding RNA in macrophages by proinflammatory stimuli," PLoS ONE, vol. 8, no. 6, Article ID e68306, 2013.
23. M. Guttman, I. Amit, M. Garber et al., "Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals," Nature, vol. 458, no. 7235, pp. 223-227, 2009.
24. Z. Li, T. C. Chao, K. Y. Chang et al., "The long noncoding RNA THRIL regulates TNFalpha expression through its interaction with hnRNPL," Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 3, pp. 1002-1007, 2014.
25. M. Krawczyk and B. M. Emerson, "p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-kappaB complexes," eLife, vol. 3, Article ID e01776, 2014.
26. P. W. Wright, A. Huehn, F. Cichocki et al., "Identification of a KIR antisense lnc RNA expressed by progenitor cells," Genes and Immunity, vol. 14, no. 7, pp. 427-433, 2013.
27. L. Shi, Z. Zhang, A. M. Yu et al., "The SLE transcriptome exhibits evidence of chronic endotoxin exposure and has widespread dysregulation of non-coding and coding RNAs," PLoS ONE, vol. 9, no. 5, Article ID e93846, 2014.
28. N. Müller, F. Döring, M. Klapper et al., "Interleukin-6 and Tumour Necrosis Factor-α differentially regulate lincRNA transcripts in cells of the innate immune system in vivo in human subjects with rheumatoid arthritis," Cytokine, vol. 68, no. 1, pp. 65-68, 2014.
29. E. Sonkoly, Z. Bata-Csorgo, A. Pivarcsi et al., "Identification and characterization of a novel, psoriasis susceptibility-related noncoding RNA gene, PRINS," The Journal of Biological Chemistry, vol. 280, no. 25, pp. 24159-24167, 2005.
30. O. Wapinski and H. Y. Chang, "Long noncoding RNAs and human disease," Trends in Cell Biology, vol. 21, no. 6, pp. 354-361, 2011.
31. C. P. Ponting, P. L. Oliver, and W. Reik, "Evolution and functions of long noncoding RNAs," Cell, vol. 136, no. 4,pp. 629-641, 2009.
32. V. A. Moran, R. J. Perera, and A. M. Khalil, "Emerging functional and mechanistic paradigms of mammalian long noncoding RNAs," Nucleic Acids Research, vol. 40, no. 14, pp. 6391-6400, 2012.
33. P. Kapranov, J. Cheng, S. Dike et al., "RNA maps reveal new RNA classes and a possible function for pervasive transcription," Science, vol. 316, no. 5830, pp. 1484-1488, 2007.
34. T. Kino, D. E. Hurt, T. Ichijo, N. Nader, and G. P. Chrousos, "Noncoding RNA Gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor," Science Signaling, vol. 3, no. 107, p. ra8, 2010.
35. M. Guttman and J. L. Rinn, "Modular regulatory principles of large non-coding RNAs," Nature, vol. 482, no. 7385, pp. 339-346, 2012.
36. M. Cabili, C. Trapnell, L. Goff et al., "Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses," Genes and Development, vol. 25, no. 18, pp. 1915-1927, 2011.
37. I. Ulitsky and D. P. Bartel, "XLincRNAs: genomics, evolution, and mechanisms," Cell, vol. 154, no. 1, pp. 26-46, 2013.
38. J. T. Y. Kung, D. Colognori, and J. T. Lee, "Long noncoding RNAs: past, present, and future," Genetics, vol. 193, no. 3, pp. 651-669, 2013.
39. A. C. Marques and C. P. Ponting, "Intergenic lncRNAs and the evolution of gene expression," Current Opinion in Genetics & Development, vol. 27, no. 48, pp. 48-53, 2014.
40. Y. Ogawa, B. K. Sun, and J. T. Lee, "Intersection of the RNA interference and X-inactivation pathways," Science, vol. 320, no. 5881, pp. 1336-1341, 2008.
41. F. Sleutels, R. Zwart, and D. P. Barlow, "The non-coding Air RNA is required for silencing autosomal imprinted genes," Nature, vol. 415, no. 6873, pp. 810-813, 2002.
42. J. L. Rinn, M. Kertesz, J. K. Wang et al., "Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs," Cell, vol. 129, no. 7, pp. 1311-1323, 2007.
43. H. T. Zheng, D. B. Shi, Y. W. Wang et al., "High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer," International Journal of Clinical and Experimental Pathology, vol. 7, no. 6, pp. 3174-3181, 2014.
44. M. Huarte, M. Guttman, D. Feldser et al., "A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response," Cell, vol. 142, no. 3, pp. 409-419, 2010.
45. N. Ishii, K. Ozaki, H. Sato et al., "Identification of a novel noncoding RNA, MIAT, that confers risk of myocardial infarction," Journal of Human Genetics, vol. 51, no. 12, pp. 1087-1099, 2006.
46. Y.-S. Huang, H.-Y. Hsieh, H.-M. Shih, H.-K. Sytwu, and C.-C. Wu, "Urinary Xist is a potential biomarker for membranous nephropathy," Biochemical and Biophysical Research Communications, vol. 452, no. 3, pp. 415-421, 2014.
47. K. A. Fitzgerald and D. R. Caffrey, "Long noncoding RNAs in innate and adaptive immunity," Current Opinion in Immunology, vol. 26, no. 1, pp. 140-146, 2014.
48. G. C. Tsokos, "Systemic lupus erythematosus," The New England Journal of Medicine, vol. 365, no. 22, pp. 2110-2121, 2011.
49. S. L. Foster, D. C. Hargreaves, and R. Medzhitov, "Gene-specific control of inflammation by TLR-induced chromatin modifications," Nature, vol. 447, no. 7147, pp. 972-978, 2007.
50. S. L. Doyle and L. A. J. O'Neill, "Toll-like receptors: from the discovery of NFκB to new insights into transcriptional regulations in innate immunity," Biochemical Pharmacology, vol. 72, no. 9, pp. 1102-1113, 2006.
51. R. Dai and S. A. Ahmed, "MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases," Translational Research, vol. 157, no. 4, pp. 163-179, 2011.
52. R. P. Singh, I. Massachi, S. Manickavel et al., "The role of miRNA in inflammation and autoimmunity," Autoimmunity Reviews, vol. 12, no. 12, pp. 1160-1165, 2013.
53. + T-cell differentiation," Immunological Reviews, vol. 253, no. 1, pp. 82-96, 2013.
54. S. Vigneau, P.-S. Rohrlich, M. Brahic, and J.-F. Bureau, "Tmevpg1, a candidate gene for the control of Theiler's virus persistence, could be implicated in the regulation of gamma interferon," Journal of Virology, vol. 77, no. 10, pp. 5632-5638, 2003.
55. C. Mauri and A. Bosma, "Immune regulatory function of B cells," Annual Review of Immunology, vol. 30, pp. 221-241, 2012.
56. D. J. Bolland, A. L. Wood, C. M. Johnston et al., "Anti-sense intergenic transcription in V(D)J recombination," Nature Immunology, vol. 5, no. 6, pp. 630-637, 2004.
57. N. Stoy, "Macrophage biology and pathobiology in the evolution of immune responses: a functional analysis," Pathobiology, vol. 69, no. 4, pp. 179-211, 2001.
58. E. Vivier, D. H. Raulet, A. Moretta et al., "Innate or adaptive immunity? The example of natural killer cells," Science (New York, N.Y.), vol. 331, no. 6013, pp. 44-49, 2011.
59. C.-C. Liu, A. H. Kao, S. Manzi, and J. M. Ahearn, "Biomarkers in systemic lupus erythematosus: challenges and prospects for the future,"Therapeutic Advances in Musculoskeletal Disease, vol. 5, no. 4, pp. 210-233, 2013.
60. B. Rhodes and T. J. Vyse, "The genetics of SLE: an update in the light of genome-wide association studies," Rheumatology, vol. 47, no. 11, pp. 1603-1611, 2008.
61. M. H. Biermann, S. Veissi, C. Maueröder et al., "The role of dead cell clearance in the etiology and pathogenesis of systemic lupus erythematosus: dendritic cells as potential targets," Expert Review of Clinical Immunology, vol. 10, no. 9, pp. 1151-1164, 2014.
62. L. E. Muñoz, C. Janko, C. Schulze et al., "Autoimmunity and chronic inflammation - two clearance-related steps in the etiopathogenesis of SLE," Autoimmunity Reviews, vol. 10, no. 1, pp. 38-42, 2010.
63. J. S. Smolen, D. Aletaha, M. Koeller, M. H. Weisman, and P. Emery, "New therapies for treatment of rheumatoid arthritis," The Lancet, vol. 370, no. 9602, pp. 1861-1874, 2007.
64. I. Duroux-Richard, C. Jorgensen, and F. Apparailly, "miRNAs and rheumatoid arthritis - promising novel biomarkers," Swiss Medical Weekly, vol. 141, Article ID w13175, 2011.
65. G. Stassi and R. de Maria, "Autoimmune thyroid disease: new models of cell death in autoimmunity," Nature Reviews Immunology, vol. 2, no. 3, pp. 195-204, 2002.
66. R. I. Fox, "Sjögren's syndrome," The Lancet, vol. 366, no. 9482, pp. 321-331, 2005.
67. S. Gaidamakov, O. A. Maximova, H. Chon et al., "Targeted deletion of the gene encoding the La autoantigen (Sjögren's syndrome antigen b) in b cells or the frontal brain causes extensive tissue loss,"Molecular and Cellular Biology, vol. 34,no. 1, pp. 123-131, 2014.
68. A. Triantafyllopoulou, N. Tapinos, and H. M. Moutsopoulos, "Evidence for coxsackievirus infection in primary Sjögren's syndrome," Arthritis and Rheumatism, vol. 50, no. 9, pp. 2897-2902, 2004.